Drug shortages

Ketorolac Tromethamine Injection

Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other

Current0641-6042-25Analgesia/Addiction
Open FDA's page for this record
Update type
Reverified
Initial posting date
06/06/2018
Package NDC
0641-6042-25
Generic name
Ketorolac Tromethamine Injection
Contact info
800-631-2174
Availability
Unavailable
Related info
Estimated recovery: TBD
Update date
09/18/2026
Dosage form
Injection
Presentation
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25)
Company name
Hikma Pharmaceuticals USA, Inc.
Shortage reason
Other
Status
Current
Therapeutic category
Analgesia/Addiction
Harmonized identifiers (openFDA)
Application number
ANDA075772
Brand name
KETOROLAC TROMETHAMINE
Generic name
KETOROLAC TROMETHAMINE
Manufacturer name
Hikma Pharmaceuticals USA Inc.
Product NDC
0641-6042, 0641-6043, 0641-6041
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAMUSCULAR, INTRAVENOUS
Substance name
KETOROLAC TROMETHAMINE
RxCUI
860092, 1665459, 1665461
SPL ID
25d6c438-45d2-4162-91c2-b5caa0f86bf3
SPL set ID
0c2c75c9-ed7b-46a8-9543-429bf2d8f090
Package NDC
0641-6043-01, 0641-6043-25, 0641-6042-01, 0641-6042-25, 0641-6041-01, 0641-6041-25
UNII
4EVE5946BQ
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.